VYNE (STOCKS)
VYNE Therapeutics Inc. Common Stock
$0.558400
+0.001200 (+0.22%)
Prev close: $0.557200
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David Domzalski
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $18.65M
- Employees
- 13
- P/E (TTM)
- -0.71
- P/B (TTM)
- 0.55
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.17 | $-0.13 | -0.0374 | -28.21% |
|
Jun 2025 (Q2)
|
$-0.13 | $-0.23 | +0.0978 | +42.93% |
|
Mar 2025 (Q1)
|
$-0.20 | $-0.30 | +0.0958 | +32.39% |
|
Dec 2024 (Q4)
|
$-0.28 | $-0.31 | +0.0294 | +9.50% |
Financial Statements
| Revenues | $476.00K |
| Benefits Costs and Expenses | $38.99M |
| Costs And Expenses | $43.08M |
| Operating Expenses | $43.08M |
| Research and Development | $30.94M |
| Other Operating Expenses | $12.14M |
| Operating Income/Loss | -$42.60M |
| Income/Loss From Continuing Operations After Tax | -$38.52M |
| Income/Loss From Continuing Operations Before Tax | -$38.52M |
| Income/Loss From Discontinued Operations Net Of Tax | -$24.00K |
| Income Tax Expense/Benefit | $4.00K |
| Net Income/Loss | -$38.55M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$38.55M |
| Net Income/Loss Available To Common Stockholders, Basic | -$38.55M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.91 |
| Diluted Earnings Per Share | -$0.91 |
| Basic Average Shares | 85,300,000 |
| Diluted Average Shares | 85,300,000 |
| Assets | $44.72M |
| Current Assets | $44.34M |
| Noncurrent Assets | $375.00K |
| Fixed Assets | $102.00K |
| Other Non-current Assets | $273.00K |
| Liabilities | $5.84M |
| Current Liabilities | $5.84M |
| Wages | $819.00K |
| Other Current Liabilities | $5.02M |
| Noncurrent Liabilities | $0.00 |
| Long-term Debt | $0.00 |
| Equity | $38.88M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $38.88M |
| Liabilities And Equity | $44.72M |
| Net Cash Flow From Operating Activities | -$39.77M |
| Net Cash Flow From Operating Activities, Continuing | -$39.77M |
| Net Cash Flow From Investing Activities | $32.42M |
| Net Cash Flow From Investing Activities, Continuing | $32.42M |
| Net Cash Flow From Financing Activities | -$255.00K |
| Net Cash Flow From Financing Activities, Continuing | -$255.00K |
| Net Cash Flow | -$7.61M |
| Net Cash Flow, Continuing | -$7.61M |
| Comprehensive Income/Loss | -$38.49M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$38.49M |
| Other Comprehensive Income/Loss | $56.00K |